IHE IHE

IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?

The Motley Fool · 2d ago

iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns

The Motley Fool · 40d ago

GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.

The Motley Fool · 54d ago

Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything

The Motley Fool · 111d ago

Where Will Eli Lilly Be in 10 Years?

The Motley Fool · 174d ago

Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors?

The Motley Fool · 284d ago

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms

Benzinga · 295d ago

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

Zacks Investment Research · 752d ago

Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?

Zacks Investment Research · 761d ago

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Zacks Investment Research · 762d ago

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Zacks Investment Research · 802d ago

A Look at Pharma ETFs Post Q1 Earnings

Zacks Investment Research · 804d ago

ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook

Zacks Investment Research · 810d ago

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market

Benzinga · 811d ago

JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus

Zacks Investment Research · 824d ago

Time to Tap Healthcare ETFs on Nvidia's AI Ambition?

Zacks Investment Research · 837d ago

Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors

Benzinga · 875d ago

Looking for Bargain Hunting? Top-Ranked ETFs to Buy

Zacks Investment Research · 878d ago

5 ETFs at All-Time Highs as S&P 500 Rally Continues

Zacks Investment Research · 885d ago